Detalhe da pesquisa
1.
Avanzando Caminos (Leading Pathways): Design and Procedures of The Hispanic/Latino Cancer Survivorship Study.
Am J Epidemiol
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576195
2.
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysis.
Diabetes Obes Metab
; 26(5): 1929-1940, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389430
3.
BIPOC experiences of (anti-)racist patient engagement in adolescent and young adult oncology research: an electronic Delphi study.
Future Oncol
; 20(9): 547-561, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197386
4.
The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer.
Oncologist
; 28(10): e921-e929, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943395
5.
The Effect of Biomarker Use on the Speed and Duration of Clinical Trials for Cancer Drugs.
Oncologist
; 27(10): 849-856, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993585
6.
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
Lancet Oncol
; 22(7): 959-969, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118197
7.
Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non-small cell lung cancer: A network meta-analysis of randomized trials.
Cancer
; 127(5): 709-719, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119177
8.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Lancet
; 395(10241): 1907-1918, 2020 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473681
9.
Impact of COVID-19 Infection on Patients with Cancer: Experience in a Latin American Country: The ACHOCC-19 Study.
Oncologist
; 26(10): e1761-e1773, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132449
10.
Clinical trial risk in leukemia: Biomarkers and trial design.
Hematol Oncol
; 39(1): 105-113, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078436
11.
A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy.
Future Oncol
; 17(28): 3743-3756, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34263658
12.
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
Br J Cancer
; 122(3): 340-347, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31761899
13.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 393(10183): 1819-1830, 2019 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955977
14.
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1189, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32347358
15.
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1177-1187, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32140762
16.
Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue.
Oncologist
; 24(3): 394-401, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413665
17.
EGFR Mutation Testing: Changing Patterns of Molecular Testing in Brazil.
Oncologist
; 24(4): e137-e141, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446583
18.
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
Oncologist
; 24(6): 820-828, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867242
19.
Cost-Effectiveness of Cabozantinib in the Second-Line Treatment of Advanced Hepatocellular Carcinoma.
J Natl Compr Canc Netw
; 17(6): 669-675, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200357
20.
Changing global policy to deliver safe, equitable, and affordable care for women's cancers.
Lancet
; 389(10071): 871-880, 2017 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27814964